{"id":201463,"date":"2026-08-13T13:40:19","date_gmt":"2026-08-13T08:10:19","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=201463"},"modified":"2026-08-13T13:40:19","modified_gmt":"2026-08-13T08:10:19","slug":"why-ipca-laboratories-ltd-share-price-rise-2026-08-13","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-ltd-share-price-rise-2026-08-13\/","title":{"rendered":"Ipca Laboratories Ltd. (IPCALAB) Share Price Rises 3.08% Today; Price Action in Focus"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\">Ipca Laboratories Ltd.<\/a> traded at Rs 1821.1, up 3.08% today, taking its market capitalisation to Rs 44,380.48 crore and placing it among notable large-cap gainers.<\/p>\n<p style=\"margin-top:0!important;\">Ipca Laboratories Ltd. Share Price was at Rs 1821.1 on 13 August 2026, up Rs 54.4 or 3.08% from the previous close of Rs 1766.7, lifting the company\u2019s market capitalisation to Rs 44,380.48 crore. That makes Ipca Laboratories Ltd. Share Price Today one of the more visible large-cap moves in the healthcare pack during the session, and it is why the stock has entered the day\u2019s top gainer discussion.<\/p>\n<p>The verified data confirms a clear same-day price rise, with the stock opening at Rs 1780, moving within a day range of Rs 1766.3 to Rs 1828, and trading close to the upper end of that band at the time of this update. Total traded volume stood at 2,83,689 shares across exchanges, including 2,61,024 shares on NSE and 22,665 shares on BSE, while reported turnover was Rs 4.13 crore. For investors tracking Ipca Laboratories Ltd. Stock News, that combination shows both price strength and active participation.<\/p>\n<p>What the supplied data does not establish is a company-specific catalyst. So, while today\u2019s move is fully verified, Univest notes that the available figures confirm the price event itself rather than the exact reason behind it. Even so, the stock\u2019s gain is large enough to matter in Stock Market Today screens, especially because it qualified under the workflow\u2019s large-cap price-rise event filter. From here, the important questions are whether the move held through the session, how the volume profile compares with the broader market, and how the company sits against healthcare sector benchmarks and listed peers. That is where this Univest stock analysis becomes useful for readers searching Ipca Laboratories Ltd. Share Price, Ipca Laboratories Ltd. Share Price Today and Ipca Laboratories Ltd. Stock News.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Ipca_Laboratories_Ltd_IPCALAB_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Ipca Laboratories Ltd. (IPCALAB) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,821.1<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,766.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 54.4 (+3.08%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,780<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,828<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,766.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume (BSE)<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22,665<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>BSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22,665<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>NSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2,61,024<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Combined NSE + BSE Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2,83,689<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4.13 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 44,380.48 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/table>\n<p>Ipca Laboratories Ltd. (IPCALAB) traded at Rs 1,821.1. versus the previous close of Rs 1,766.7, a rise of 3.08%. The stock opened at Rs 1,780, reached Rs 1,828, touched Rs 1,766.3. Reported volume was 22,665.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Ipca_Laboratories_Ltd_IPCALAB_Fundamental_Analysis\"><\/span><strong>Ipca Laboratories Ltd. (IPCALAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 44,380.48 crore<\/td>\n<\/tr>\n<\/table>\n<p>Ipca Laboratories Ltd. Fundamental Analysis, based strictly on the supplied data, is less about a full balance-sheet reading and more about company size, market context and how much valuation framing investors can draw from today\u2019s move. The most important verified number here is market capitalisation of Rs 44,380.48 crore, which places the company firmly in the large-cap bracket and makes today\u2019s 3.08% share price gain notable in size-adjusted terms.<\/p>\n<p>That market cap matters because it gives context to the day\u2019s move. A 3.08% rise in a company valued at Rs 44,380.48 crore is very different from the same percentage move in a much smaller stock. In Market News and Stocks in News screens, investors usually pay attention when a large-cap healthcare company posts a clean intraday advance while remaining close to the day\u2019s high. This is one reason Ipca Laboratories Ltd. Share Price has drawn attention even without a verified company-specific trigger in the supplied data.<\/p>\n<p>At the same time, the current data set does not include company-specific P\/E ratio, P\/B ratio, EV\/EBITDA, ROE, ROCE, EPS, book value, dividend yield, revenue, net profit, debt-to-equity, operating cash flow or free cash flow figures for Ipca Laboratories Ltd. That means today\u2019s fundamental analysis must stay disciplined and factual. The stock\u2019s relevance today comes from the combination of its size, its place within the Healthcare sector, and the fact that it recorded a meaningful same-day gain rather than merely drifting higher on low visibility.<\/p>\n<p>For investors following Ipca Laboratories Ltd. Financial Results, Ipca Laboratories Ltd. Earnings or broader company financials, the current session alone does not change the underlying business picture. Instead, it raises a monitoring question: does the stock\u2019s price action continue to attract interest relative to the healthcare benchmark and peer group? That is why Univest treats today\u2019s rise as a data point worth watching rather than a standalone conclusion about business quality or valuation. From here, the ownership picture would normally add another layer, but the strongest verified context in this case comes from sector and peer comparisons.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.05x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">74.83x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.44x to 3,374.81x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.93x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.07%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 44,380.48 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 140.78 crore<\/td>\n<\/tr>\n<\/table>\n<p>Ipca Laboratories Ltd. (IPCALAB) is classified under sector: Healthcare.<\/p>\n<p>Track today&#8217;s top gainers through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<p>The healthcare benchmark data gives the clearest broader context for today\u2019s move. Ipca Laboratories Ltd. sits in the Healthcare sector, and the supplied benchmark covers 196 companies in the same sector. Those figures show a wide valuation and profitability spread across the group, which helps explain why stock-specific price rises can attract close attention.<\/p>\n<p>The sector benchmark scope is listed as the same sector, with 196 companies in total. Within that universe, P\/E data is available for 154 companies, showing a median of 26.05 and an average of 74.83. The range is unusually broad, stretching from 3.44 to 3374.81. That spread matters because it tells investors that healthcare valuations are far from uniform; instead, the sector includes both low-multiple and very high-multiple names. For anyone tracking Ipca Laboratories Ltd. Share Price News, today\u2019s rise is therefore taking place inside a sector where relative positioning can vary sharply.<\/p>\n<p>The benchmark also shows P\/B data for 195 companies, with a median of 1.93 and an average of 2.59, while the range runs from -16.89 to 16.74. On profitability, median ROE stands at 11.07% and average ROE at 15.45% across 195 companies. Median ROCE is 13.35% and average ROCE is 17.79%, again based on 195 companies. These benchmark numbers help frame sector quality, even though the supplied data set does not include the equivalent company-specific profitability ratios for Ipca Laboratories Ltd.<\/p>\n<p>Market-cap distribution within the benchmark is also striking. The median company market cap is Rs 140.78 crore, and the average is Rs 466.2 crore, with a minimum of Rs 3.87 crore and a maximum of Rs 3027.48 crore among the benchmark companies listed in the sector snapshot. Against that backdrop, Ipca Laboratories Ltd. Market Cap of Rs 44,380.48 crore is far larger than the benchmark median and average. In practical terms, this means today\u2019s 3.08% move came in a stock whose size already places it well above much of the benchmark universe, which is one reason the price rise stands out in Indian Stock Market coverage. Univest sees that as an important part of the context around Ipca Laboratories Ltd. Share Price Today.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,027.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,958.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">68.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hikal\/hikal-ltd-share-price-today\"><strong>Hikal Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HIKAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,686.72<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,596.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/saiparent\/sai-parenteral-s-ltd-share-price-today\"><strong>Sai Parenteral&#39;s Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAIPARENT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,559.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">171.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.97<\/td>\n<\/tr>\n<\/table>\n<p>Ipca Laboratories Ltd. (IPCALAB) has a market capitalisation of Rs 44,380.48 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<p>The peer snapshot shows that Ipca Laboratories Ltd. is being viewed against a set of listed healthcare names with much smaller market capitalisations than its own Rs 44,380.48 crore. That size gap is the first major takeaway, because it means today\u2019s rise occurred in a company substantially larger than the peers included in the supplied comparison list.<\/p>\n<p>The peer group includes Dishman Carbogen Amcis Ltd. at Rs 3027.48 crore, Beta Drugs Ltd. at Rs 2958.04 crore, Hikal Ltd. at Rs 2686.72 crore, Dr Agarwals Eye Hospital Ltd. at Rs 2596.51 crore and Sai Parenteral&#8217;s Ltd. at Rs 2559.74 crore, with the remaining peers also clustered below Rs 2500 crore. Compared with those figures, Ipca Laboratories Ltd. Market Cap is multiple times larger than every named peer in the snapshot. That alone gives the stock a different weight in Market Movers and Top Gainers Today discussions.<\/p>\n<p>Among peers where P\/E is supplied, Beta Drugs trades at 68.39, Dr Agarwals Eye Hospital at 34.07, Sai Parenteral&#8217;s at 171.25, Ind-Swift Laboratories at 44.25, NGL Fine-Chem at 43.8 and Sakar Healthcare at 57.68. On P\/B, the peer set ranges from 0.77 for Dishman Carbogen Amcis to 10.82 for Beta Drugs, with other examples including 2.2 for Hikal, 7.02 for Dr Agarwals Eye Hospital, 3.13 for Sai Parenteral&#8217;s and 1.91 for Solara Active Pharma Sciences. Profitability is equally mixed: NGL Fine-Chem shows ROE of 27.9% and ROCE of 33.91%, while Dishman Carbogen Amcis shows ROE of -2.89% and ROCE of -0.26%. Hikal reports ROE of 15.22% and ROCE of 16.15%, and Solara shows ROE of 17.23% and ROCE of 15.34%.<\/p>\n<p>The broader conclusion is not that Ipca Laboratories Ltd. is better or worse than any one peer, because the company-specific valuation and profitability ratios needed for that direct judgement are not present in the supplied data. The verified takeaway is narrower and still useful: Ipca Laboratories Ltd. Share Price is being watched after a meaningful rise in a company far larger than the listed peers, while the peer group itself displays wide variation in valuation multiples and returns ratios. That makes relative analysis important for readers following Ipca Laboratories Ltd. Stock Analysis and sector positioning.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Ipca_Laboratories_Ltd\"><\/span><strong>Why Investors Are Watching Ipca Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors are watching Ipca Laboratories Ltd. Share Price because today\u2019s move combined a visible large-cap gain with trading near the session high and meaningful exchange participation. In a healthcare sector where benchmark valuations and profitability levels vary widely, a 3.08% price rise in a Rs 44,380.48 crore company quickly becomes relevant in daily stock screens and market conversations.<\/p>\n<ul>\n<li><strong>Verified price action:<\/strong> the stock rose Rs 54.4 to Rs 1821.1 from a previous close of Rs 1766.7.<\/li>\n<li><strong>Intraday strength:<\/strong> it traded in a Rs 61.7 band between Rs 1766.3 and Rs 1828 and stayed close to the high.<\/li>\n<li><strong>Volume profile:<\/strong> total volume stood at 2,83,689 shares, with 2,61,024 on NSE and 22,665 on BSE.<\/li>\n<li><strong>Large-cap context:<\/strong> market capitalisation is Rs 44,380.48 crore, making the move significant in size-adjusted terms.<\/li>\n<li><strong>Sector positioning:<\/strong> the healthcare benchmark spans 196 companies with wide ranges in P\/E, P\/B, ROE and ROCE.<\/li>\n<li><strong>Peer backdrop:<\/strong> the supplied peers are all much smaller, sharpening focus on this move.<\/li>\n<\/ul>\n<p>What investors may monitor next is whether Ipca Laboratories Ltd. Share Price Live continues to hold a large part of today\u2019s gain, whether turnover remains healthy, and how the stock behaves relative to other healthcare names. Univest also sees value in watching whether follow-through in price action is accompanied by comparable visibility in future company updates, financial disclosures and sector-wide movement.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Ipca_Laboratories_Ltd\"><\/span><strong>About Ipca Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ipca Laboratories Ltd. is represented in the supplied data as a listed company within the Healthcare sector. That sector classification is important because it places the stock inside one of the Indian market\u2019s most closely tracked spaces for valuation, profitability and defensive-growth discussions. For readers searching Ipca Laboratories Ltd. Latest News or Ipca Laboratories Ltd. Company News, the available data ties the company directly to healthcare market activity rather than to a broader industrial or cyclical basket.<\/p>\n<p>The comparison universe supplied alongside the stock includes companies from Pharmaceuticals &#038; Drugs and Hospital &#038; Healthcare Services, which shows the range of business models present in the same broad sector benchmark. That matters because the healthcare label can include businesses with very different margins, capital intensity and valuation multiples. In other words, sector membership alone does not tell investors everything about financial quality or market positioning, but it does establish the competitive and analytical context in which the stock is being judged.<\/p>\n<p>For Ipca Laboratories Ltd. Share Price watchers, the most relevant immediate fact is that the company is a large-cap healthcare name with a market capitalisation of Rs 44,380.48 crore. That scale clearly differentiates it from the benchmark median company and from every peer listed in the supplied snapshot. On Univest, that makes the stock worth tracking not only for daily price action but also for how it behaves relative to the broader healthcare opportunity set. In practical terms, the company\u2019s current market standing means its moves can attract attention across Stock Updates, NSE News and BSE News even when the supplied data does not point to a single confirmed catalyst.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Ipca_Laboratories_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Ipca Laboratories Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\">Ipca Laboratories Ltd. (IPCALAB) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top gainers lists and related market analysis.<\/p>\n<p>Investors who want to follow Ipca Laboratories Ltd. Share Price more closely can use Univest to track live share price moves, day range behaviour, market capitalisation changes and broader stock analysis in one place. Univest also helps users monitor technical indicators when available, compare sector benchmarks, review peer positioning, study 52-week levels and follow shareholding pattern updates when disclosed.<\/p>\n<p>For readers checking Ipca Laboratories Ltd. Share Price Today, Ipca Laboratories Ltd. Share Price Update or Ipca Laboratories Ltd. Share Price Live, a structured platform matters because a single-day rise is most useful when viewed with surrounding context. That includes price action, turnover, relative sector standing and company-specific disclosures as they emerge. Univest is built to organise those market insights without turning them into a recommendation.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Ipca_Laboratories_Ltd_Share_Price_today\"><\/span><strong>What is Ipca Laboratories Ltd. Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ipca Laboratories Ltd. Share Price today was Rs 1821.1 at the time captured in the supplied data. The stock was up Rs 54.4 from the previous close of Rs 1766.7, translating into a 3.08% gain.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Ipca_Laboratories_Ltd_Share_Price_rising_today\"><\/span><strong>Why is Ipca Laboratories Ltd. Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms that Ipca Laboratories Ltd. Share Price rose 3.08% in today\u2019s session and qualified under the large-cap price-rise screen. However, the verified figures establish the move itself rather than a company-specific catalyst behind it.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Ipca_Laboratories_Ltd_stock_gain_in_todays_trade\"><\/span><strong>How much did Ipca Laboratories Ltd. stock gain in today\u2019s trade?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ipca Laboratories Ltd. stock gained Rs 54.4 in absolute terms and 3.08% in percentage terms during the session covered here. It moved from a previous close of Rs 1766.7 to a current price of Rs 1821.1.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_intraday_range_for_Ipca_Laboratories_Ltd_Share_Price_Today\"><\/span><strong>What was the intraday range for Ipca Laboratories Ltd. Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ipca Laboratories Ltd. Share Price Today traded between a day low of Rs 1766.3 and a day high of Rs 1828. The stock opened at Rs 1780 and was trading close to the upper end of that range.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Ipca_Laboratories_Ltd\"><\/span><strong>What is the market capitalisation of Ipca Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ipca Laboratories Ltd. had a market capitalisation of Rs 44,380.48 crore in the supplied session snapshot. That places it in the Large Cap category and makes today\u2019s 3.08% move more significant in size-adjusted market terms.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_active_was_trading_in_Ipca_Laboratories_Ltd_on_NSE_and_BSE\"><\/span><strong>How active was trading in Ipca Laboratories Ltd. on NSE and BSE?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Total traded volume stood at 2,83,689 shares. Of this, 2,61,024 shares were traded on NSE and 22,665 shares on BSE, while the reported turnover for the captured session was Rs 4.13 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_sector_does_Ipca_Laboratories_Ltd_belong_to\"><\/span><strong>Which sector does Ipca Laboratories Ltd. belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ipca Laboratories Ltd. belongs to the Healthcare sector according to the supplied data. The benchmark used for comparison covers 196 companies in the same sector, showing wide spreads in valuation and profitability metrics.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Ipca_Laboratories_Ltd_compare_with_the_healthcare_benchmark_on_size\"><\/span><strong>How does Ipca Laboratories Ltd. compare with the healthcare benchmark on size?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Ipca Laboratories Ltd. is much larger than the benchmark median and average healthcare company in the supplied sector set. Its market cap is Rs 44,380.48 crore versus a benchmark median of Rs 140.78 crore and average of Rs 466.2 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_healthcare_sector_benchmark_show_right_now\"><\/span><strong>What does the healthcare sector benchmark show right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The healthcare benchmark shows a median P\/E of 26.05 and average P\/E of 74.83 across 154 companies. Median ROE is 11.07% and median ROCE is 13.35%, indicating varied valuation and profitability across the sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_are_investors_watching_Ipca_Laboratories_Ltd_Stock_News_today\"><\/span><strong>Why are investors watching Ipca Laboratories Ltd. Stock News today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors are watching Ipca Laboratories Ltd. Stock News because the stock delivered a 3.08% same-day price rise, stayed near its day high of Rs 1828, and did so as a large-cap healthcare company with Rs 44,380.48 crore market value.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ipca Laboratories Ltd. Share Price rises to Rs Rs 1,821.1. marking a 3.08% rise today. clearing the 3% threshold for Large Cap stocks. Market cap stands at Rs<\/p>\n","protected":false},"author":29,"featured_media":201462,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-201463","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["201462"],"rank_math_title":["Ipca Laboratories Ltd. Share Price News: Price Rise Analysis"],"rank_math_description":["Ipca Laboratories Ltd. Share Price rose 3.08% today to Rs 1821.1. Read price action, market cap, sector benchmark and peer analysis in one place."],"rank_math_focus_keyword":["Ipca Laboratories Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Ipca_Laboratories_Ltd_IPCALAB_Share_Price_Rises_308_Today_Price_Action_in_Focus_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/201463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=201463"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/201463\/revisions"}],"predecessor-version":[{"id":201464,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/201463\/revisions\/201464"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/201462"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=201463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=201463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=201463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}